Vestor Capital LLC Purchases 600 Shares of Colgate-Palmolive (NYSE:CL)

Vestor Capital LLC raised its position in shares of Colgate-Palmolive (NYSE:CL) by 38.5% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,160 shares of the company’s stock after buying an additional 600 shares during the quarter. Vestor Capital LLC’s holdings in Colgate-Palmolive were worth $224,000 as of its most recent SEC filing.

A number of other large investors have also added to or reduced their stakes in CL. E Fund Management Hong Kong Co. Ltd. bought a new position in Colgate-Palmolive during the second quarter valued at $25,000. Continuum Advisory LLC increased its stake in Colgate-Palmolive by 46.5% during the second quarter. Continuum Advisory LLC now owns 394 shares of the company’s stock worth $38,000 after acquiring an additional 125 shares during the last quarter. Reston Wealth Management LLC purchased a new stake in Colgate-Palmolive during the third quarter valued at approximately $42,000. Gradient Investments LLC lifted its stake in shares of Colgate-Palmolive by 150.4% in the 2nd quarter. Gradient Investments LLC now owns 666 shares of the company’s stock valued at $65,000 after purchasing an additional 400 shares during the last quarter. Finally, Financial Connections Group Inc. purchased a new position in shares of Colgate-Palmolive in the 2nd quarter worth approximately $68,000. Institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Trading Down 0.4 %

NYSE CL opened at $93.33 on Monday. Colgate-Palmolive has a 52 week low of $74.22 and a 52 week high of $109.30. The company has a 50 day moving average price of $102.26 and a 200 day moving average price of $98.35. The company has a quick ratio of 0.28, a current ratio of 1.04 and a debt-to-equity ratio of 9.46. The firm has a market cap of $76.25 billion, a PE ratio of 26.74, a price-to-earnings-growth ratio of 3.35 and a beta of 0.42.

Colgate-Palmolive Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Friday, October 18th will be paid a dividend of $0.50 per share. The ex-dividend date is Friday, October 18th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.14%. Colgate-Palmolive’s payout ratio is 57.31%.

Wall Street Analyst Weigh In

A number of analysts recently issued reports on CL shares. Morgan Stanley raised their price target on Colgate-Palmolive from $103.00 to $111.00 and gave the stock an “overweight” rating in a research report on Monday, July 29th. StockNews.com cut shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a research note on Tuesday, October 29th. Piper Sandler started coverage on shares of Colgate-Palmolive in a research report on Tuesday, September 24th. They issued an “overweight” rating and a $121.00 price objective on the stock. Barclays boosted their target price on Colgate-Palmolive from $91.00 to $96.00 and gave the company an “equal weight” rating in a research report on Monday, July 29th. Finally, Sanford C. Bernstein increased their price target on Colgate-Palmolive from $100.00 to $103.00 and gave the stock a “market perform” rating in a report on Tuesday, July 30th. One research analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, Colgate-Palmolive currently has a consensus rating of “Hold” and a consensus target price of $105.11.

Insider Activity at Colgate-Palmolive

In other Colgate-Palmolive news, Director Martina Hundmejean sold 2,313 shares of the company’s stock in a transaction that occurred on Friday, August 23rd. The shares were sold at an average price of $103.86, for a total transaction of $240,228.18. Following the transaction, the director now owns 11,755 shares in the company, valued at approximately $1,220,874.30. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. In other news, Director Martina Hundmejean sold 2,313 shares of the firm’s stock in a transaction dated Friday, August 23rd. The stock was sold at an average price of $103.86, for a total value of $240,228.18. Following the completion of the transaction, the director now directly owns 11,755 shares in the company, valued at $1,220,874.30. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, insider Sally Massey sold 15,850 shares of the company’s stock in a transaction that occurred on Tuesday, August 6th. The shares were sold at an average price of $103.28, for a total value of $1,636,988.00. Following the completion of the sale, the insider now owns 13,942 shares in the company, valued at approximately $1,439,929.76. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 43,490 shares of company stock valued at $4,486,063 in the last three months. 0.34% of the stock is owned by insiders.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.